Guardian Pharmacy Services (GRDN) reported Q4 earnings Wednesday of $0.19 per diluted share.
Three analysts polled by FactSet expected earnings of $0.22 per diluted share.
The company completed its initial public offering in September 2024.
Revenue for the quarter ended Dec. 31 was $338.6 million, up from $281.1 million a year ago.
Three analysts surveyed by FactSet expected $332.8 million.
The company said it expects full-year 2025 revenue between $1.33 billion and $1.35 billion.
Three analysts polled by FactSet expect $1.34 billion.
Shares of Guardian Pharmacy were down 0.3% in after-hours trading.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。